Opko Health Inc (OPK)
$2.41
0.01 (0.41%)
OPK Stock Quote Delayed 30 Minutes
Previous Close
$2.42
Market Cap
1.35B
PE Ratio
-4.23
EPS
-0.57
Volume (Avg. Vol.)
3.70M
Day's Range
2.36 - 2.49
52-Week Range
1.12 - 2.91
Dividend & Yield
N/A (N/A)
OPK Stock Predictions, Articles, and Opko Health Inc News
Roche Holding News: RHHBY Stock Jumps 8% on Faster Coronavirus Test
Roche Holding (RHHBY) news for Friday includes an update on testing for the coronavirus from China with approval from the FDA.
OPKO Health News: Why OPK Health Stock Is Soaring 30% Today
OPKO Health (OPK) news for Friday concerning new testing for the coronavirus from China in New York has OPK stock soaring higher.
OPK Stock Rockets 13% Higher on Coronavirus Test Announcement
Opko Health (OPK) is seeing OPK stock head higher on Friday following an announcement concerning a test for the coronavirus from China.
3 Big Stock Charts for Tuesday: Apple, Scana and Procter & Gamble
Stock charts of AAPL, PG and SCG have earned a closer look from traders as today's session gets started.
3 Big Stock Charts for Monday: PG&E, Oracle and Weyerhaeuser
The stock charts of PCG, WY and ORCL are run through the technical trading wringer. Here's the next likely move for all three.
OPKO Stock Had a Great Q2 and the Future Looks Even Better
With shares nearly double where they were in May, OPKO Health, Inc. (NASDAQ:OPK) needed a strong second-quarter earnings report to justify the gains in OPKO....
Friday’s Vital Data: Nvidia Corporation (NVDA), Netflix, Inc. (NFLX) and Opko Health Inc. (OPK)
Nvidia (NVDA) options jump on Bosch deal, Bernstein believes in Netflix (NFLX) and Opko Health (OPK) initiated at Guggenheim.
Thursday’s Vital Data: Facebook Inc (FB), Opko Health Inc. (OPK) and Nvidia Corporation (NVDA)
Facebook (FB) eyes streaming video, Opko Health (OPK) options spike amid kidney drug release and Nvidia (NVDA) upgraded at Evercore ISI.
24 Biotechnology Stocks to Sell Now
This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
32 Biotechnology Stocks to Sell Now
This week, the overall grades of 32 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
25 Biotechnology Stocks to Buy Now
25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
3 Big Stock Charts for Tuesday: International Business Machines Corp. (IBM), Amazon.com, Inc. (AMZN) and Opko Health Inc. (OPK)
Opko Health (OPK), International Business Machines (IBM) and Amazon (AMZN) continue to heat-up the summer trading season by offering chart watchers some attractive bullish breakout opportunities.
3 Stocks to Watch on Tuesday: Apple Inc. (AAPL), Opko Health Inc. (OPK) and Rackspace Hosting, Inc. (RAX)
Apple Inc. (AAPL) fends off Russian allegations, Opko Health (OPK) surges on strong earnings and Rackspace (RAX) offers up a mixed plate.
5 Stocks With Awful Earnings Revisions — PHH OPK APPS ONDK RAS
This week, these five stocks have the worst ratings in Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
3 Stocks to Watch on Tuesday: CarMax, Inc (KMX), Lennar Corporation (LEN) and Opko Health Inc. (OPK)
Opko Health (OPK) is charging on an FDA treatment approval and Lennar (LEN) is cruising on an earnings beat. CarMax (KMX) could have a rough Tuesday, however.
Opko Health Inc.: FDA Denial Won’t Kill OPK
The approval delay of Rayaldee, Opko Health's new billion-dollar drug, won't hurt its market performance. OPK is a high-risk/high-reward stock.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
